Fundraising FoxVytronUS
Sunnyvale, US · Delaware corporation · 3 known investors
Find your way into VytronUS
Sign up to see every warm intro you have to VytronUS
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VytronUS team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JP
John PavlidisExecutive
MH
Michael HorzewskiExecutive
MP
Michael PedersonExecutive
Board
DM
David McIntyreBoard director
JK
Justin KleinBoard director
SH
Sami HamadeBoard director
JM
John MaroneyBoard director
DG
David GallupBoard director
PJ
Peter Justin KleinBoard director
JN
John NehraBoard director
RT
Roy TanakaBoard director
AJ
A. Jay GrafBoard director
Investors · 3
New Enterprise Associates (NEA)listed by New Enterprise Associates (NEA)Menlo Park · $200K – $40M
How we know: funding news · prnewswire.com · Not right? Tell us
Windham Capital Partnerslisted by Windham Capital PartnersNew York · $1M – $5M
How we know: funding news · prnewswire.com · Not right? Tell us
BioStar VenturesreportedPetoskey
How we know: funding news · prnewswire.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$46.5M disclosed across 3 of 4 rounds · 2009–2016
▶$30MraisedAug 2016 · 20 investors · Other Health CareRule 506(b)
▶$30MraisedAug 2016 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John PavlidisExecutive Officer, Director
- David McIntyreDirector
- Roy TanakaDirector
- A. Jay GrafDirector
- Justin KleinDirector
- Sami HamadeDirector
- Hank KuchemanDirector
- Offering amount
- $59M
- Amount sold
- $30M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.8MraisedSep 2014 · 7 investors · Other Health CareRule 506(b)
▶$7.8MraisedSep 2014 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- A. Jay GrafDirector
- Justin KleinDirector
- Roy TanakaDirector
- Michael PedersonExecutive Officer, Director
- Offering amount
- $33M
- Amount sold
- $7.8M
- Minimum investment
- $1
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.7MraisedFeb 2012 · 3 investors · Other Health CareRule 506(b)
▶$8.7MraisedFeb 2012 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John MaroneyDirector
- David GallupDirector
- Roy TanakaDirector
- Michael HorzewskiExecutive Officer, Director
- Peter Justin KleinDirector
- John NehraDirector
- A.Jay GrafDirector
- Michael PedersonExecutive Officer, Director
- Offering amount
- $13M
- Amount sold
- $8.7M
- Minimum investment
- $1
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are VytronUS's investors?
- VytronUS's investors include New Enterprise Associates (NEA), Windham Capital Partners, BioStar Ventures.
- How much funding has VytronUS raised?
- VytronUS has disclosed $46.5M raised across 3 of its 4 known rounds.
- Where is VytronUS headquartered?
- VytronUS is headquartered in Sunnyvale, US.